|Values are valid only on day of printing.|
This test looks for a broad spectrum of prescription and over-the-counter (OTC) drugs. It is designed to detect drugs that have toxic effects, as well as known antidotes or active therapies that a clinician can initiate to treat the toxic effect. The test is intended to help physicians manage an apparent overdose or intoxicated patient, or to determine if a specific set of symptoms might be due to the presence of drugs. This test is not appropriate for drugs of abuse or illicit drug testing, including benzodiazepines, opioids, barbiturates, cocaine, amphetamine type stimulants.
Drugs of toxic significance that are not detected by this test are: digoxin, lithium, and many drugs of abuse or illicit drugs, some benzodiazepines, and some opioids.
See Prescription and Over-the-Counter (OTC) Drug Screens in Special Instructions for detection limits for drugs detected in this test.
Detection and identification of prescription or over the counter drugs frequently found in drug overdose or used with a suicidal intent
This test is designed to qualitatively identify drugs present in the specimen; quantification of identified drugs, when available, may be performed upon client request
The drugs that are detected by this test are listed in Prescription and Over-the-Counter (OTC) Drug Screens in Special Instructions.
The pharmacology of each drug determines how the test should be interpreted. A detailed discussion of each drug is beyond the scope of this text. If you wish to have a report interpreted, call Mayo Medical Laboratories and ask for a toxicology consultant.
Each report will indicate the drugs detected.
Not intended for therapeutic compliance testing.
Not intended for use in employment-related testing.
This test is not appropriate for drugs of abuse or illicit drug testing, including benzodiazepines, opioids, barbiturates, cocaine, amphetamine type stimulants.For situations where chain of custody is required, order DSSX / Drug Screen, Prescription/OTC, Chain of Custody, Serum.
Drugs detected are presumptive. Additional testing may be required to confirm the presence of any drugs detected.
1. Langman LJ, Bechtel L, Holstege CP: Clinical toxicology. In Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Edited by CA Burtis, ER Ashwood, DE Bruns. Fifth edition. St. Louis, MO, Elsevier Saunders, 2012 pp 1109-1188
2. Disposition of Toxic Drugs and Chemicals in Man. 10th edition. Edited by RC Baselty. South Beach CA, Biomedical Publications, 2014